NeuroPace, Inc. (NPCE) — Analyst outlook / Analyst consensus target is. Based on 10 analyst ratings, the consensus is bullish — 9 Buy, 1 Hold.
The consensus price target is $19.00 (low: $16.00, high: $22.00), representing an upside of 23.8% from the current price $15.35.
Analysts estimate Earnings Per Share (EPS) of $-0.98 and revenue of $0.08B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.93 vs est $-0.98 (beat +5.3%). 2025: actual $-0.66 vs est $-0.77 (beat +13.7%). Analyst accuracy: 89%.
NPCE Stock — 12-Month Price Forecast
$19.00
▲ +23.78% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for NeuroPace, Inc., the average price target is $19.00, with a high forecast of $22.00, and a low forecast of $16.00.
The average price target represents a +23.78% change from the last price of $15.35.
Highest Price Target
$22.00
Average Price Target
$19.00
Lowest Price Target
$16.00
NPCE Analyst Ratings
Buy
Based on 10 analysts giving stock ratings to NeuroPace, Inc. in the past 3 months
EPS Estimates — NPCE
89%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$0.93
vs Est –$0.98
▲ 5.6% off
2025
Actual –$0.66
vs Est –$0.77
▲ 15.9% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — NPCE
97%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.080B
vs Est $0.080B
▲ 0.4% off
2025
Actual $0.100B
vs Est $0.095B
▲ 4.9% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
